Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer.
Dendritic cells (DC) loaded with tumor antigens from apoptotic/necrotic tumor cells are commonly used as vaccines for cancer therapy. However, the use of dead tumor cells may cause both tolerance and immunity, making the effect of vaccination unpredictable. To deliver live tumor "cargoes" into DC, we developed a new approach based on the "labeling" of tumors with a phospholipid "eat-me" signal, phosphatidylserine. Expression of phosphatidylserine on live tumor cells mediated their recognition and endocytosis by DC resulting in the presentation of tumor antigens to antigen-specific T cells. In mice, topical application of phosphatidylserine-containing ointment over melanoma induced tumor-specific CTL, local and systemic antitumor immunity, and inhibited tumor growth. Thus, labeling of tumors with phosphatidylserine is a promising strategy for cancer immunotherapy.
Shurin
Michael R
MR
Department of Pathology and Immunology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. shurinmr@upmc.edu
Potapovich
Alla I
AI
Tyurina
Yulia Y
YY
Tourkova
Irina L
IL
Shurin
Galina V
GV
Kagan
Valerian E
VE
D000818:Animals; D017951:Antigen Presentation; D003713:Dendritic Cells / Q000276:immunology*; D007167:Immunotherapy / Q000379:methods; D007371:Interferon-gamma / Q000172:deficiency / Q000235:genetics / Q000276:immunology; D008213:Lymphocyte Activation; D016399:Lymphoma, T-Cell / Q000276:immunology / Q000628:therapy*; D008297:Male; D008546:Melanoma, Experimental / Q000276:immunology / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D016513:Mice, SCID; D010718:Phosphatidylserines / Q000008:administration & dosage* / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
D010718:Phosphatidylserines; D007371:Interferon-gamma